Ingalls & Snyder LLC’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24K | Hold |
11,415
| – | – | ﹤0.01% | 442 |
|
|
2025
Q1 | $25K | Sell |
11,415
-2,000
| -15% | -$4.38K | ﹤0.01% | 430 |
|
|
2024
Q4 | $21K | Hold |
13,415
| – | – | ﹤0.01% | 425 |
|
|
2024
Q3 | $27K | Hold |
13,415
| – | – | ﹤0.01% | 433 |
|
|
2024
Q2 | $47K | Hold |
13,415
| – | – | ﹤0.01% | 406 |
|
|
2024
Q1 | $37K | Buy |
13,415
+2,000
| +18% | +$5.52K | ﹤0.01% | 419 |
|
|
2023
Q4 | $19K | Hold |
11,415
| – | – | ﹤0.01% | 420 |
|
|
2023
Q3 | $12K | Hold |
11,415
| – | – | ﹤0.01% | 413 |
|
|
2023
Q2 | $13K | Hold |
11,415
| – | – | ﹤0.01% | 413 |
|
|
2023
Q1 | $17K | Hold |
11,415
| – | – | ﹤0.01% | 407 |
|
|
2022
Q4 | $29K | Sell |
11,415
-2,700
| -19% | -$6.86K | ﹤0.01% | 411 |
|
|
2022
Q3 | $60K | Hold |
14,115
| – | – | ﹤0.01% | 397 |
|
|
2022
Q2 | $39K | Buy |
+14,115
| New | +$39K | ﹤0.01% | 416 |
|